Halozyme Therapeutics (HALO) PT Raised to $22 at JPMorgan
Tweet
Share
E-mailGet Alerts HALO Hot Sheet
Price: $69.96 +1.41%
Rating Summary:
14 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
14 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
JPMorgan raised its price target on Halozyme Therapeutics (NASDAQ: HALO) to $22.00 (from $19.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Darling Ingredients (DAR) PT Lowered to $70 at TD Cowen
- Globe Life (GL) PT Raised to $215 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
